EA201070092A1 - Адаптация вируса бешенства штамма pitman moore к первичной клеточной культуре фибробластов куриных эмбрионов - Google Patents

Адаптация вируса бешенства штамма pitman moore к первичной клеточной культуре фибробластов куриных эмбрионов

Info

Publication number
EA201070092A1
EA201070092A1 EA201070092A EA201070092A EA201070092A1 EA 201070092 A1 EA201070092 A1 EA 201070092A1 EA 201070092 A EA201070092 A EA 201070092A EA 201070092 A EA201070092 A EA 201070092A EA 201070092 A1 EA201070092 A1 EA 201070092A1
Authority
EA
Eurasian Patent Office
Prior art keywords
virus
cell culture
primary cell
fibroblastes
adaptation
Prior art date
Application number
EA201070092A
Other languages
English (en)
Other versions
EA020998B1 (ru
Inventor
Прадип Маганлал Пател
Панкадж Раманбхай Пател
Original Assignee
Кадила Хелзкэр Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кадила Хелзкэр Лимитед filed Critical Кадила Хелзкэр Лимитед
Publication of EA201070092A1 publication Critical patent/EA201070092A1/ru
Publication of EA020998B1 publication Critical patent/EA020998B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Настоящее изобретение относится к способу адаптации штамма Pitman Moore вируса бешенства к первичной клеточной культуре куриных фибробластов для получения антирабической вакцины.
EA201070092A 2007-07-03 2008-04-24 Способ получения антирабической вакцины путём адаптации штамма pitman moore EA020998B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1275MU2007 2007-07-03
PCT/IN2008/000262 WO2009004641A2 (en) 2007-07-03 2008-04-24 Adaptation of pitman moore strain of rabies virus to primary chick embryo fibroblast cell cultures

Publications (2)

Publication Number Publication Date
EA201070092A1 true EA201070092A1 (ru) 2010-06-30
EA020998B1 EA020998B1 (ru) 2015-03-31

Family

ID=54252438

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201070092A EA020998B1 (ru) 2007-07-03 2008-04-24 Способ получения антирабической вакцины путём адаптации штамма pitman moore

Country Status (9)

Country Link
US (1) US8361776B2 (ru)
EP (2) EP2187962B1 (ru)
CN (1) CN101730544B (ru)
AU (1) AU2008272428B2 (ru)
BR (1) BRPI0812612A2 (ru)
CA (1) CA2691629C (ru)
EA (1) EA020998B1 (ru)
IL (1) IL202925A (ru)
WO (1) WO2009004641A2 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102988974B (zh) * 2012-12-14 2015-05-20 山东滨州沃华生物工程有限公司 一种用传代鸡胚成纤维细胞制备猪伪狂犬活疫苗的方法
CN103468649B (zh) * 2013-10-08 2015-04-08 云南沃森生物技术股份有限公司 人用狂犬疫苗毒种在人二倍体细胞上的快速适应方法
CN103865888B (zh) * 2014-04-03 2016-03-23 深圳市卫光生物制品股份有限公司 狂犬病病毒ctn-1株对原代鸡胚成纤维细胞的适应方法
CN103865889B (zh) * 2014-04-03 2015-02-25 深圳市卫光生物制品股份有限公司 狂犬病病毒ctn鸡胚细胞适应株
CN109119168B (zh) * 2018-06-28 2022-03-22 中国农业科学院特产研究所 一种鸡胚的测试方法和系统、存储介质

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2616407C3 (de) * 1976-04-14 1980-02-21 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Tollwut-Impfstoffs
US20060275776A1 (en) * 2005-06-01 2006-12-07 Angelika Banzhoff Rabies vaccine

Also Published As

Publication number Publication date
CA2691629A1 (en) 2009-01-08
WO2009004641A3 (en) 2009-02-26
US20100189746A1 (en) 2010-07-29
EP2187962B1 (en) 2015-03-11
CN101730544A (zh) 2010-06-09
EA020998B1 (ru) 2015-03-31
US8361776B2 (en) 2013-01-29
AU2008272428B2 (en) 2012-08-30
EP2540313A1 (en) 2013-01-02
CN101730544B (zh) 2014-07-30
EP2187962A2 (en) 2010-05-26
BRPI0812612A2 (pt) 2015-12-22
IL202925A (en) 2015-09-24
WO2009004641A2 (en) 2009-01-08
AU2008272428A1 (en) 2009-01-08
CA2691629C (en) 2014-07-08

Similar Documents

Publication Publication Date Title
CL2012000590A1 (es) Proceso para preparar w-transaminasa (r)-selectiva.
EA201200537A1 (ru) Способ получения глюкопиранозил-замещенных производных бензилбензола
UA110600C2 (uk) Спосіб отримання захищених похідних l-аланіну
EA201490886A1 (ru) Переработка биомассы
IT1393929B1 (it) Procedimento per la produzione di bio-olio da biomassa
UA108208C2 (xx) Пестицидні композиції
BR112012024799A2 (pt) método para a produção de l-ornitina por fermentação
UY33852A (es) ?moléculas de ácido nucleico que se dirigen a la proteína de unión a gtp pequeña de rho1 y que confieren resistencia a las plagas de coleópteros?.
BRPI1009189A2 (pt) método para melhorar o rendimento de um polipetídeo
UA111142C2 (uk) Одержання заміщених похідних 2-фторакрилової кислоти
WO2010023310A3 (en) The an3 protein complex and its use for plant growth promotion
BRPI0917169A2 (pt) método para a produção de álcool concentrado a partir de caldo de fermentação
MY163339A (en) A method of producing ingenol-3-angelate
DK2281053T3 (da) Fremstilling af biobrændstof af plantevævskulturkilder
WO2013052995A3 (en) Improved developmental competence of oocytes
DK2627775T3 (da) Fremgangsmåde til fremstilling af bioethanol ved enzymatisk hydrolyse af cellulose
BR112013007263A2 (pt) desmanosilação de n-glicanos fosforilados
EA201070092A1 (ru) Адаптация вируса бешенства штамма pitman moore к первичной клеточной культуре фибробластов куриных эмбрионов
EA201590772A1 (ru) Способ повышения устойчивости к абиотическому стрессу в растениях с использованием производных карбоксамида или тиокарбоксамида
MX2010005701A (es) Metodo para producir cepa viral vacunal de un virus de la familia reoviridae.
MX2009006943A (es) Procedimiento para la mejor utilizacion del potencial de produccion de plantas transgenicas.
BR112013005689A2 (pt) método para produção de compostos de piridazinona e intermediário dos mesmos
BRPI0921003A2 (pt) processo para uma instalção para produzir bioetanol.
MX2013014969A (es) Metodo para preparar zeolitas tipo lta utilizando un agente director de estructura novedoso.
EA201100902A1 (ru) Новый способ получения рнк-вируса

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU